Effects of acute euglycemic hyperinsulinemia on urinary nitrite/nitrate excretion and plasma endothelin-1 levels in men with essential hypertension and normotensive controls

Metabolism: Clinical and Experimental

Volumn 48, Issue 7, 1999, Pages 887-891

  Surdacki, Andrzej ^a   Nowicki, Michal ^a   Sandmann, Joerg ^a   Tsikas, Dimitrios ^a   Kruszelnicka Kwiatkowska, Olga ^a   Kokot, Franciszek ^a   Dubiel, Jacek S ^a   Froelich, Juergen C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; NITRATE; NITRITE;

ADULT; ARTICLE; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; URINARY EXCRETION;

EID: 0032993705     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90224-X     Document Type: Article

References (56)

1. Ferri C, Pittoni V, Piccoli A, et al: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 80:829-835, 1995
2. Leyva F, Wingrove C, Felton C, et al: Physiological hyperinsulinemia is not associated with alterations in venous plasma levels of endothelin-1 in healthy individuals. Metabolism 40:1137-1139, 1997
3. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98:894-898, 1996
4. Piatti PM, Monti LD, Conti M, et al: Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 45:316-321, 1996
5. Wolpert HA, Steen SN, Istfan NW, et al: Insulin modulates endothelin-1 levels in humans. Metabolism 42:1027-1030, 1993
6. Polderman KH, Stehouwer CDA, van Kamp GJ, et al: Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia 39:1284-1292, 1996
7. Seljeflot I, Moan A, Aspelin T, et al: Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type I angiotensin receptor antagonist or placebo. Metabolism 47:292-296, 1998
8. Steinberg HO, Brechtel G, Johnson A, et al: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
9. Scherrer U, Randin D, Vollenweider P, et al: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
10. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
11. Capaldo B, Lembo G, Napoli R, et al: Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 40:1320-1322, 1991
12. G-monomethyl-L-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal. J Hypertens 10:1025-1031, 1992
13. Panza JA, Casino PA, Kilcoyne CM, et al: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87:1468-1474, 1993
14. Baron AD: The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes 45:S105-S109, 1996 (suppl 1)
15. Feldman RD, Hramiak IM, Finegood DT, et al: Parallel regulation of the local vascular and systemic metabolic effects of insulin. J Clin Endocrinol Metab 80:1556-1559, 1995
16. Utriainen T, Maekimattila S, Virkamaeki A, et al: Physical fitness and endothelial function (nitric oxide synthesis) are independent determinants of insulin-stimulated blood flow in normal subjects. J Clin Endocrinol Metab 81:4258-4263, 1996
17. Natali A, Taddei S, Quiñones Salvan A, et al: Insulin sensitivity, vascular reactivity, and clamp-induced vasodilation in essential hypertension. Circulation 96:849-855, 1997
18. Petrie JR, Ueda S, Webb DJ, et al: Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 93:1331-1333, 1996
19. Utriainen T, Maekimattila S, Virkamaeki A, et al: Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia 39:1477-1482, 1996
20. Avogaro A, Piarulli F, Valerio A, et al: Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 46:1040-1046, 1997
21. Taddei S, Virdis A, Mattei P, et al: Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 92:2911-2918, 1995
22. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2011, 1993
23. Jungersten L, Edlund A, Petersson AS, et al: Plasma nitrate as an index of nitric oxide formation in man: Analyses of kinetics and confounding factors. Clin Physiol 16:369-379, 1996
24. Grabowski PS, England AJ, Dykhuizen R, et al: Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate:creatinine ratio. Arthritis Rheum 39:643-647, 1996
25. DeFronzo RA, Tobin J, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
26. Boeger RH, Bode-Boeger SM, Thiele W, et al: Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95:2068-2074, 1997
27. 15N-labelled analogs. J Chromatogr B 661:185-191, 1994
28. - excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine and L-NAME in rats. Clin Exp Pharmacol Physiol 23:11-15, 1996
29. Haenni A, Berglund L, Reneland R, et al: The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance. Am J Hypertens 10:145-151, 1997
30. Ferri C, Bellini C, Desideri G, et al: Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care 19:504-506, 1996
31. Andronico G, Mangano M, Ferrara L, et al: In vivo relationship between insulin and endothelin role of insulin-resistance. J Hum Hypertens 11:63-66, 1997
32. Boulanger C, Luescher TF: Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85:587-590, 1990
33. Ahlborg G, Lundberg JM: Nitric oxide-endothelin-1 interaction in humans. J Appl Physiol 82:1593-1600, 1997
34. Anderson EA, Hoffman RP, Balon TW, et al: Hyperinsulinemia produces both sympathetic and neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252, 1991
35. Wagner OF, Christ G, Wojta JJ, et al: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267:16066-16068, 1992
36. Cardillo C, Nambi SS, Kilcoyne CM, et al: Local hyperinsulinemia increases endothelin activity in the human forearm circulation. J Am Coll Cardiol 31:507A, 1998 (suppl A, abstr)
37. Tsukahara H, Ende H, Magazine HI, et al: Molecular and functional characterization of the non-peptide-selective ETB receptor in endothelial cells: Receptor coupling to nitric oxide synthase. J Biol Chem 269:21778-21785, 1994
38. Verhaar MC, Strachan FE, Newby DE, et al: Endothelin - A receptor antagonist-mediated vasodilation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97:752-756, 1998
39. 38a. Cardillo C, Kilcoyne CM, Waclawiw M, et al: Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 33:753-758, 1999
40. Berne C, Fagius J, Pollare T, et al: The sympathetic response to euglycemic hyperinsulinemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 35:873-879, 1992
41. Hausberg M, Mark AL, Hoffman RP, et al: Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens 13:1015-1021, 1995
42. Cocks TM, Angus JA: Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627-629, 1983
43. 2- and β-adrenergic responses in human forearm. J Clin Invest 100:2007-2014, 1997
44. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
45. 2-adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension 30:1128-1134, 1997
46. Skarphedinsson JO, Elam M, Jungersten L, et al: Sympathetic nerve traffic correlates with the release of nitric oxide in humans. J Physiol (Lond) 501:671-675, 1997
47. - excretion. Metabolism 46:406-409, 1997
48. Fragasso G, Piatti P, Monti L, et al: Imbalance between basal and insulin-stimulated endothelin release, nitric oxide release and muscle glucose metabolism in patients with syndrome X. J Am Coll Cardiol 31:85A, 1998 (suppl A, abstr)
49. Piatti PM, Monti LD, Velsecchi G, et al: Effects of low-dose heparin infusion on arterial endothelin-1 release in humans. Circulation 94:2703-2707, 1996
50. Higashi Y, Oshima T, Sasaki N, et al: Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension 29:280-285, 1997
51. Giugliano D, Marfella R, Verrazzo G, et al: The vascular effects of L-arginine in humans. The role of endogenous insulin. J Clin Invest 99:433-438, 1997
52. 18F]fluoro-2-deoxy-D-glucose, and positron emission tomography. Diabetes 45:1471-1477, 1996
53. Laine H, Yki-Jaervinen H, Kirvelae O, et al: Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 101:1156-1162, 1998
54. Tack CJ, Ong MK, Lutterman JA, et al: Insulin-induced vasodilation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 41:569-576, 1998
55. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000, 1989
56. Haynes WG, Webb DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344:852-854, 1994